A Trial Investigating the Effect of a Treatment With Zinkgluconaat for Verrucae Vulgares
Phase 2
Completed
- Conditions
- Verrucae Vulgares
- Registration Number
- NCT00228332
- Lead Sponsor
- University Hospital, Ghent
- Brief Summary
A Double-blind, placebo-controlled trial investigating the effect of a treatment with zinkgluconaat for verrucae vulgares
- Detailed Description
A Double-blind, placebo-controlled trial investigating the effect of a treatment with zinkgluconaat for verrucae vulgares
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
- Patients with verrucae vulgares
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Disappearence of the verrucae vulgares after 3 months
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the efficacy of zinc gluconate in treating verrucae vulgaris?
How does zinc gluconate compare to salicylic acid in clearing common warts?
Are there specific biomarkers that predict response to zinc-based treatments for viral warts?
What are the potential adverse events associated with topical zinc gluconate therapy for verrucae?
What combination therapies have shown improved outcomes for warts compared to zinc gluconate alone?
Trial Locations
- Locations (1)
University Hospital Ghent
🇧🇪Ghent, Belgium
University Hospital Ghent🇧🇪Ghent, Belgium